drugset / Trial / NCT00821691
Action of Amantadine on Post-Stroke Aphasic Patients
RandomizedCrossoverDouble-blindTreatment
Summary
The objective of the study is to test the action of the amantadine, as DOPA-agonist, in a double blind cross-over trial, amantadine / placebo, on the verbal fluency of chronic post stroke aphasic patients.
Timeline
- Start
- 2009-03
- Primary completion
- 2013-04
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amantadin | Unknown | 100 mg | — |